National Heart and Lung Institute, Imperial College London, London, UK.
Eur Respir J. 2013 Mar;41(3):548-55. doi: 10.1183/09031936.00132011. Epub 2012 Jun 27.
This study aimed to compare strategies for chronic obstructive pulmonary disease (COPD) case finding using data from the Burden of Obstructive Lung Disease study. Population-based samples of adults aged ≥40 yrs (n = 9,390) from 14 countries completed a questionnaire and spirometry. We compared the screening efficiency of differently staged algorithms that used questionnaire data and/or peak expiratory flow (PEF) data to identify persons at risk for COPD and, hence, needing confirmatory spirometry. Separate algorithms were fitted for moderate/severe COPD and for severe COPD. We estimated the cost of each algorithm in 1,000 people. For moderate/severe COPD, use of questionnaire data alone permitted high sensitivity (97%) but required confirmatory spirometry in 80% of participants. Use of PEF necessitated confirmatory spirometry in only 19-22% of subjects, with 83-84% sensitivity. For severe COPD, use of PEF achieved 91-93% sensitivity, requiring confirmatory spirometry in <9% of participants. Cost analysis suggested that a staged screening algorithm using only PEF initially, followed by confirmatory spirometry as needed, was the most cost-effective case-finding strategy. Our results support the use of PEF as a simple, cost-effective initial screening tool for conducting COPD case-finding in adults aged ≥40 yrs. These findings should be validated in real-world settings such as the primary care environment.
本研究旨在比较使用来自负担性阻塞性肺病研究的数据进行慢性阻塞性肺疾病(COPD)病例发现的策略。来自 14 个国家的≥40 岁的成年人进行了基于人群的抽样调查,他们完成了一份问卷和肺量测定。我们比较了使用问卷数据和/或呼气峰流速(PEF)数据来识别有 COPD 风险并需要确认肺量测定的患者的不同分期算法的筛查效率。针对中度/重度 COPD 和重度 COPD 分别制定了单独的算法。我们估计了在 1000 人中每种算法的成本。对于中度/重度 COPD,单独使用问卷数据可获得高敏感性(97%),但需要对 80%的参与者进行确认性肺量测定。仅使用 PEF 需要确认性肺量测定的参与者占 19-22%,敏感性为 83-84%。对于重度 COPD,使用 PEF 可实现 91-93%的敏感性,仅需对<9%的参与者进行确认性肺量测定。成本分析表明,最初仅使用 PEF 进行分阶段筛查算法,然后根据需要进行确认性肺量测定,是最具成本效益的病例发现策略。我们的结果支持使用 PEF 作为一种简单、具有成本效益的初始筛查工具,用于≥40 岁成年人的 COPD 病例发现。这些发现应在真实环境中(如初级保健环境)进行验证。